Full Length Research Paper
References
|
Adeleye AI, Onubogu CC, Ayolabi CI, Isawumi AO, Nshiogu ME (2008). Screening of twelve medicinal plants and 'wonder-cure' concoction used in Nigeria unorthodox medicine for activity against Mycobacterium tuberculosis patients sputum. African Journal of Infectious Diseases 2(2). |
|
|
Ammal RM, Bar GVS (2013). GC-MS determination of bioactive constituents of Heliotropium indicum leaf. Journal of Medicinal Plant Studies. Journal of Medicinal Plants 1(6):30-33. |
|
|
Arbex MA, Varella M de CL, Siqueira HR De, Mello FAF de (2010). Antituberculosis drug: drug interactions, adverse effects and use in special situations. Part 2: second line drugs. Jornal Brasileiro de Pneumologia 36(5):626-640. |
|
|
Boakye YD, Agyare C, Abotsi WKM, Ayande PG, Ossei PPS (2016). Anti-inflammatory activity of aqueous leaf extract of Phyllanthus muellerianus (Kuntze) Exell. and its major constituent, geraniin. Journal of Ethnopharmacology 187:17-27. |
|
|
Calligaro GL, Moodley L, Symons G, Dheda K (2014). The medical and surgical treatment of drug-resistant tuberculosis. Journal of Thoracic Disease 6(3):186. |
|
|
Copp BR (2003). Antimycobacterial natural products. Natural Product Reports 20(6):535-557. |
|
|
Doughari JH, Sunday D (2008). Antibacterial activity of Phyllanthus muellerianus. Pharmaceutical Biology 46(6):400-405. |
|
|
Elendran S, Wang LW, Prankerd R, Palanisamy UD (2015). The physicochemical properties of geraniin, a potential antihyperglycemic agent. Pharmaceutical Biology 53(12):1719-1726. |
|
|
Evina JN, Bikobo DSN, Zintchem AAA, Nyemeck (2017). In vitro antitubercular activity of extract and constituents from the stem bark of Disthemonanthus benthamianum. Revista Brasileira de Farmacognosia 27(6):739-743. |
|
|
Faleyimu OI, Akinyemi O, Adejoba OR (2009). Herbal solution to the treatment of tuberculosis infection in Kaduna south local government, Kaduna, Nigeria. Journal of Environmental Extension 8(1). |
|
|
Gautam R, Saklani A, Jachak SM (2007). Indian Medicinal Plants as a Source of Antimycobacterial Agents. Journal of Ethnopharmacology 110(2):200-234. |
|
|
Gbadamosi IT, Kalejaye AO (2017). Comparison of the antioxidant activity, phytochemical and nutritional contents of two antihypertensive ethnomedicinal plants. Ife Journal of Science 19(1):147-158. |
|
|
George OA, Adenipekun EO, Fasogbon SA, Oparanozie JA (2018). Antimicrobial Activities of Chrysophyllum albidum leaves, fruits and seeds. American Journal of Biomedical Sciences 10(1). |
|
|
Gupta R, Thakur B, Singh P, Singh HB, Sharma VD, Katoch VM, Chauhan SV (2010). Anti-tuberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates. Indian Journal of Medical Research 131(6):809. |
|
|
Ibekwe NN, Ameh SJ (2014). Plant natural products research in tuberculosis drug discovery and development: A situation report with focus on Nigerial biodiversity. African Journal of Biotechnology 13(23). |
|
|
Ilango K, Arunkumar S (2010). Synthesis and antitubercular activity of novel 2-aryl N-(3,4,5-trihydroxy benzamido)-4-thiazolidinone derivatives. Rasayan Journal of Chemistry 3:493. |
|
|
Kandel TR, Mfenyana K, Chandia J, Yogeswaran P (2008). The prevalence of and reasons for interruption of anti-tuberculosis treatment by patients at Mbekwen Health Centre in the King Sabata Dalindyebo (KSD) District in Eastern Cape Province. South African Family Practice 50(6):47-47c. |
|
|
Liu M, Grkovic T, Zhang L, Liu X, Quinn RJ (2016). A model to predict anti-tuberculosis activity: value proposition for marine micro-organisms. The Journal of Antibiotics 69(8):594 |
|
|
Lonroth K, Williams B, Stadlin S (2008). Alcohol use as a risk factor for tuberculosis-a systematic review. BMC Public Health 8(1):289. |
|
|
Mahalingam R, Bharathiadasan R, Ambikapathy V, Panneerselvam A (2011). Studies on antibacterial activity of some medicinal plants against Human pathogenic micro-organism. Asian Journal of Plant Science and Research 1(3):86-90. |
|
|
Mann A, Amupitan JO, Oyewale AO, Okogun JI, Ibrahim K, Oladosu P, Olajide I, Nnamdi A (2008). Evaluation of in vitro antmycobacterial activity of Nigerian plants used for treatment of respiratory diseases. African Journal of Biotechnology 7(11). |
|
|
Meena SL, Rajni (2010). Survival mechanism of pathogenic Mycobacterium tuberculosis H37Rv. The FEBS Journal 277(11):2416-2427. |
|
|
Ogu AC (2011). Anti-tuberculosis activities of medicinal plants used in the treatment of tuberculosis in HIV patients in Nigeria. African Journal of Microbiology Research 5(10):1126-1130. |
|
|
Olasehinde GI, Okolie ZV, Oniha MI, Adekeye BT, Ajayi AA (2015). In vitro antibacterial and antifungal activities of Chrysophyllum albidum and Diospyros monbuttensis leaves. Journal of Pharmacognosy and Phytotherapy 7 p. |
|
|
Olokor S (2017). Nigeria has 4th TB infection rate worldwide report. Punch https://punchng.com/nigeria-has-4th-tb-infection-rate-worldwide-report/ |
|
|
Onyedum CC, Alobu I, Ukwaja KN (2017). Prevalence of drug-resistant tuberculosis in Nigeria. A systematic review and meta-analysis. PloS One 12(7):e0180996. |
|
|
Pieters J (2008). Mycobacterium tuberculosis and the macrophage: Maintaining a balance. Cell Host and Microbe 3(6):399-407. |
|
|
Prasad R, Singh A, Balasubramanian V, Gupta N (2017). Extensively drug-resistant tuberculosis in India: current evidence on diagnosis & management. The Indian Journal of Medical Research 145(3):271. |
|
|
Queval CJ, Song O-R, Carralot J-P (2017). Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling. Cell Reports 20(13):3188-3198. |
|
|
Rehm J, Samokhvalov AV, Neuman MG (2009). The association between alcohol, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 9(1):450. |
|
|
Rousseau C, Winter N, Pivert E, Jackson M (2004). Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection. Cellular Microbiology 6(3):277-287. |
|
|
Seegert AB, Rudolf F, Wejse C, Neupane D (2017). Tuberculosis and hypertension – a systematic review of the literature. International Journal of Infectious Diseases 56:54-61. |
|
|
Shashidhar M, Sandhya MS, Pankaj P, Suhasini B (2015). Herbal Drugs as Anti-tuberculosis Agents. International Journal of Ayurvedic and Herbal Medicine 4:1895-1900. |
|
|
Shu YZ (1998). Recent natural products based drug development: a pharmaceutical industry perspective. Journal of Natural Products 61(8):1053-1071. |
|
|
Sotgiu G, Centis R, D'ambrosio L, Mighosi GB (2015). Tuberculosis treatment and drug regimens. Cold Spring Harbor perspectives in medicine a017822. |
|
|
Tchinda AT, Lona J, Esterd V, Cieckiewicz E, Ledoux A, Angenot L, Tits M, Balde AM, Frédérich M, Jansen O (2016). Study of Mezoneuron benthamianum, a plant traditionally used against malaria in Guinea. Planta Medica 82(S 01):406. |
|
|
Tribuddharat C, Fennewald M (1999). Integron mediated rifampin resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 43(4):960-962. |
|
|
World Health Organization (WHO) (2007). Global TB control report: epidemic leveling off. |
|
|
World Health Organization (WHO) (2018). Latent tuberculosis infection (LTBI)-FAQs, |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
